Vir Biotechnology, Inc. VIR Total costs & expenses

Total costs & expenses at other companies

AmgenAMGN

$6.54B+0.3%

Regeneron PharmaceuticalsREGN

$3B+15.5%

Gilead SciencesGILD

$18.2B+295%

BiohavenBHVN

$130.43M-41.1%

Janux TherapeuticsJANX

$41.96M-7.0%

FAQ

What is Vir Biotechnology, Inc.'s total costs & expenses?

Vir Biotechnology, Inc. (VIR) reported total costs & expenses of $165.48M in Q2 2026.

How has Vir Biotechnology, Inc.'s total costs & expenses changed year-over-year?

Vir Biotechnology, Inc.'s total costs & expenses increased by 38.3% year-over-year, from $119.63M to $165.48M.

What is the long-term trend for Vir Biotechnology, Inc.'s total costs & expenses?

Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s total costs & expenses has grown at a -5.1% compound annual growth rate (CAGR), from $674.66M to $547.88M.

What does total costs & expenses mean?

This metric aggregates all operating and non-operating costs incurred by the company to support its business activities, including research and development, selling, general, and administrative expenses. It serves as a comprehensive measure of the total capital required to maintain operations and advance the product pipeline. Analyzing this figure helps stakeholders evaluate the company's overall cost structure and operational burn rate.